Owen P. Smith

ORCID: 0000-0002-2922-2067
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Blood Coagulation and Thrombosis Mechanisms
  • Hemophilia Treatment and Research
  • Platelet Disorders and Treatments
  • Childhood Cancer Survivors' Quality of Life
  • Blood disorders and treatments
  • Immunodeficiency and Autoimmune Disorders
  • Blood groups and transfusion
  • Hematopoietic Stem Cell Transplantation
  • Hemoglobinopathies and Related Disorders
  • Chronic Myeloid Leukemia Treatments
  • Lymphoma Diagnosis and Treatment
  • Neutropenia and Cancer Infections
  • Venous Thromboembolism Diagnosis and Management
  • Sepsis Diagnosis and Treatment
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematological disorders and diagnostics
  • RNA modifications and cancer
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Eosinophilic Disorders and Syndromes
  • Cystic Fibrosis Research Advances
  • Histone Deacetylase Inhibitors Research
  • Hemostasis and retained surgical items

Children's Health Ireland at Crumlin
2014-2024

University College Dublin
2012-2024

Trinity College Dublin
2010-2024

Our Lady's Hospital
2013-2023

National Children’s Research Centre
1998-2022

University College London
1990-2021

Institute of Entomology
2021

Plant (United States)
2021

The Royal Free Hospital
1990-2021

University of Veterinary Science
2021

Natural killer (NK) cells are circulating cytotoxic lymphocytes that exert potent and nonredundant antiviral activity antitumoral in the mouse; however, their function host defense humans remains unclear. Here, we investigated 6 related patients with autosomal recessive growth retardation, adrenal insufficiency, a selective NK cell deficiency characterized by lack of CD56dim subset. Using linkage analysis fine mapping, identified disease-causing gene, MCM4, which encodes component MCM2-7...

10.1172/jci61014 article EN Journal of Clinical Investigation 2012-02-22

In pediatric relapsed acute myeloid leukemia (AML), optimal reinduction therapy is unknown. Studies suggest that liposomal daunorubicin (DNX; DaunoXome; Galen, Craigavon, United Kingdom) effective and less cardiotoxic, which important in this setting. These considerations led to a randomized phase III study by the International Berlin-Frankfurt-Münster Study Group.Patients with or primary refractory non-French-American-British type M3 AML who were younger than 21 years of age eligible....

10.1200/jco.2012.43.7384 article EN Journal of Clinical Oncology 2013-01-15
Sushree Sangita Sahoo Victor B. Pastor Charnise Goodings Rebecca Voss Emilia J. Kozyra and 91 more Amina Szvetnik Peter Noellke Michael Dworzak Jan Starý Franco Locatelli Riccardo Masetti Markus Schmugge Barbara De Moerloose Albert Catalá Krisztián Kállay Dominik Turkiewicz Henrik Hasle Jochen Buechner Kirsi Jahnukainen Marek Ussowicz Sophia Polychronopoulou Owen P. Smith Oksana Fabri Shlomit Barzilai Valérie de Haas Irith Baumann Stephan Schwarz‐Furlan Jan Starý Barbara De Moerloose Krisztián Kállay Owen P. Smith Valérie de Haas Gudrun Göhring Charlotte M. Niemeyer Karin Nebral Ingrid Simonitsch-Kluppp Pascale De Paepe Nadine Van Roy Vít Campr Zuzana Zemanová Erik Clasen‐Linde Tine Plesner Brigitte Schlegelberger Martina Rudelius Kalliopi N. Manola Kalliopi Stefanaki Judit Csomor Hajnalka Andrikovics David R. Betts Maureen J. O’Sullivan Yaniv Zohar Marta Jeison Rita De Vito Francesco Pasquali Jadwiga Małdyk Olga Haus Helena Alaiz Paula Kjöllerström Luís Mascarenhas‐Lemos Ivana Boďová Martin Čermák Lukáš Plank Barbara Gazić Marko Kavčič Helena Podgornik Margarita Llavador Ros José Cervera Carole Gengler Joëlle Tchinda Berna Beverloo Roos J. Leguit Marena R. Niewisch Martin G. Sauer Birgit Burkhardt Peter Lang Peter Bader Rita Beier Ingo Müller Michael H. Albert Roland Meisel Ansgar Schulz Gunnar Cario Pritam Kumar Panda Julius Wehrle Shinsuke Hirabayashi Marta Derecka Robert Durruthy-Durruthy Gudrun Göhring Ayami Yoshimi‐Noellke Manching Ku Dirk Lebrecht Miriam Erlacher Christian Flotho Brigitte Strahm Charlotte M. Niemeyer Marcin W. Włodarski

10.1038/s41591-021-01511-6 article EN Nature Medicine 2021-10-01

Activated protein C (APC) protects against sepsis in animal models and inhibits the lipopolysacharide (LPS)-induced elaboration of proinflammatory cytokines from monocytes. The molecular mechanism responsible for this property is unknown. We assessed effect APC on LPS-induced tumour necrosis factor alpha (TNF-alpha) production activation central transcription nuclear factor-kappaB (NF-kappaB) a THP-1 cell line. Cells were preincubated with varying concentrations (200 microg/ml, 100 microg/ml...

10.1046/j.1365-2141.2000.02128.x article EN British Journal of Haematology 2000-07-01

We have analysed the haematological parameters in 21 patients with Shwachman‐Diamond syndrome (SDS) seen over a 25‐year period at our institution. Neutropenia, although present all patients, was intermittent two‐thirds, constant rest and associated impaired chemotaxis of those tested. Fetal haemoglobin (HbF) elevated 80% some stage, anaemia thrombocytopenia documented 66% 24% respectively. Bone marrow samples were taken half patients. Myelodysplastic (MDS) developed seven (33%) five whom had...

10.1046/j.1365-2141.1996.d01-1788.x article EN British Journal of Haematology 1996-08-01

Over 13 years, we have seen 16 cases of proven invasive aspergillosis in 446 bone marrow transplant recipients, an incidence 3.6%. The infection is low patients with uncomplicated allogeneic or autologous bone-marrow transplants (< 2% and 0, respectively). Of the episodes following transplantation, 10 occurred late complications who were no longer protective isolation. In had focal pulmonary lesions (as diagnosed by computed tomographic scanning), culture bronchoalveolar lavage (BAL) fluid...

10.1093/clinids/17.3.397 article EN Clinical Infectious Diseases 1993-09-01

Abstract Juvenile myelomonocytic leukemia (JMML) is an aggressive myeloproliferative disorder of early childhood characterized by mutations activating RAS signaling. Established clinical and genetic markers fail to fully recapitulate the biological heterogeneity this disease. Here we report DNA methylome analysis mutation profiling 167 JMML samples. We identify three subgroups with unique molecular characteristics. The high methylation group (HM) somatic PTPN11 poor outcome. low enriched for...

10.1038/s41467-017-02177-w article EN cc-by Nature Communications 2017-12-08

To determine whether functional cytokine gene polymorphisms influence disease susceptibility and phenotype in patients with psoriatic arthritis (PsA).DNA was obtained from 147 PsA 389 controls. Seven proinflammatory (interleukin-1beta [IL-1beta] +3953, IL-6 -174, tumor necrosis factor alpha [TNFalpha] -308, TNFbeta +252) antiinflammatory (IL-10 -1082, IL-10 -592, IL-1 receptor antagonist [intron 2, 86 bp, variable-number tandem repeat]) were detected by polymerase chain reaction restriction...

10.1002/art.10935 article EN Arthritis & Rheumatism 2003-05-01

Unfractionated heparin (UFH) and low-molecular weight (LMWH) are well defined anticoagulant agents. Recent data suggest that both LMWH UFH may also have potent anti-inflammatory properties; however, their mechanism of action responsible for the effect is not yet fully elucidated. This study was designed to assess on human monocytes production inflammatory markers nuclear translocation factor (NF)-kappaB. Cultured were pretreated 15 min with or (10 microg 1 microg/million cells) before...

10.1111/j.1365-2141.2006.05959.x article EN British Journal of Haematology 2006-01-20

X-linked neutropenia (XLN, OMIM #300299) is a rare form of severe congenital neutropenia. It was originally described in three-generation family with five affected members that had an L270P mutation the GTP-ase binding domain (GBD) Wiskott-Aldrich syndrome protein (WASP) [Devriendt et al (2001) Nature Genetics, Vol. 27, 313-317]. Here, we report and describe large XLN, 10 males eight female carriers. A c.882T>C identified WAS gene, resulting I294T mutation. The infectious course variable...

10.1111/j.1365-2141.2008.07416.x article EN British Journal of Haematology 2008-11-06
Coming Soon ...